tradingkey.logo
tradingkey.logo
Search

Nasus Pharma Ltd

NSRX
Add to Watchlist
2.890USD
-0.085-2.86%
Close 05/15, 16:00ETQuotes delayed by 15 min
33.84MMarket Cap
LossP/E TTM
You can check out the annual or quarterly balance sheets of Nasus Pharma Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q2
FY2024Q4
Total equity
Cash, cash equivalents and short-term investments
335.56%1.24M
--203.00K
--284.00
- Cash and cash equivalents
335.56%1.24M
--203.00K
--284.00
Prepaid expenses
252.74%515.00K
--59.00K
--146.00
Other current assets
11392.59%3.10M
--29.00K
--27.00
Total current assets
962.36%4.86M
--291.00K
--457.00
Non-current assets
Net Fixed Assets
--149.00K
----
----
Other non-current assets
-100.00%0.00
--348.00K
--260.00
Total non-current assets
-42.69%149.00K
--348.00K
--260.00
Total assets
597.91%5.00M
--639.00K
--717.00
Liabilities
Current liabilities
-Other payables
-100.00%0.00
--2.56M
--1.80K
Accrued expenses
-18.34%806.00K
--1.18M
--987.00
Short-term debt and lease liabilities
----
----
--0.00
-Short-term debt
----
----
--0.00
Other current liabilities
-100.00%0.00
--2.56M
--1.80K
Total current liabilities
-44.95%2.16M
--4.95M
--3.93K
Non-current liabilities
Long-term debt and lease liabilities
--73.00K
--0.00
--0.00
-Long-term lease liabilities
--73.00K
----
----
Total non-current liabilities
--73.00K
----
----
Total liabilities
-43.09%2.24M
--4.95M
--3.93K
Shareholders' equity
Common equity
125.22%21.29M
--9.60M
--9.45K
Retained earnings
-46.24%-18.52M
---13.92M
---12.66K
Capital reserves
125.70%21.29M
--9.58M
--9.43K
Total equity
186.18%2.77M
---4.31M
---3.21K
Currency unit
USD
USD
USD
Audit opinions
--
--
--

FAQs

What is the balance sheet?

It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.
KeyAI